Author:
Sulukdjian Arek,L'homme Richard,Chanlon Audrey,Moreau Nathan
Abstract
Gabapentinoids, pregabalin and gabapentin, are neuronal voltage-gated calcium channel inhibitors mainly prescribed for the treatment of partial epilepsy and neuropathic pain. Although their efficacy as first-line treatments for painful neuropathic conditions (and several non-neuropathic painful conditions) has been well established in general medical practice, their efficacy and prescription in Oral Medicine and Oral Surgery practice has received little attention so far. This didactic article, the first of a two-part series, aims to present the experience of a French tertiary orofacial pain clinic regarding the prescription of gabapentinoids in Orofacial pain conditions that fall within the scope of the oral surgeon's practice.
Subject
Periodontics,Dentistry (miscellaneous),Oral Surgery
Reference24 articles.
1. Haute Autorité de Santé − Commission de Transparence − Avis du 3 mai 2017–prégabaline. Available at: https://has-sante.fr/upload/docs/evamed/CT-15083_LYRICA_PIS_RI_Avis2_CT9953&15083.pdf
2. Haute Autorité de Santé − Commission de Transparence − Avis du 18 avril 2018–gabapentine. Available at: https://has-sante.fr/jcms/c_2848081/fr/neurontin
3. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study
4. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
5. Moreau N, Boucher Y. Encyclopédie Médico-Chirurgicale Médecine Buccale: Douleurs oro-faciales [Article 28-290-C-10].
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献